Cholesterol medication shows potential as a novel treatment for liver cancer

A research team from the Department of Pathology at the University of Hong Kong’s LKS Faculty of Medicine (HKUMed) has discovered that atorvastatin, a widely used cholesterol-lowering drug, could become a powerful new weapon in the fight against liver cancer.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup